John L. Brottem - 01 Dec 2021 Form 4 Insider Report for Outset Medical, Inc. (OM)

Role: General Counsel
Signature: John L Brottem
Issuer symbol: OM
Transactions as of: 01 Dec 2021
Net transactions value: -$134,540
Form type: 4
Filing time: 02 Dec 2021, 15:42:31 UTC
Previous filing: 16 Nov 2021
Next filing: 04 Jan 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	OM	Common Stock	Options Exercise	$33,180	+3,500	+23%	$9.48	18,547	01 Dec 2021	Direct
transaction	OM	Common Stock	Sale	$167,720	-3,500	-19%	$47.92	15,047	01 Dec 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	OM	Performance Options (right to buy)	Options Exercise	$0	-3,500	-25%	$0.000000	10,265	01 Dec 2021	Common Stock	3,500	$9.48	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on December 14, 2020.
F2	This option vests if and to the extent that (i) the sum of (A) the 30-day closing price trading average of one Share of common stock of the Issuer ("Share") and (B) the Aggregate Cash Distributions is equal to or greater than $19.12 on any day following the expiration of the post-offering lockup period or (ii) the sum of (X) the value of all consideration that is distributable with respect to one Share in connection with a Corporate Event and (Y) the Aggregate Cash Distributions is equal to or greater than $20.86 as of the effective date of such Corporate Event.

Content

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on December 14, 2020.

This option vests if and to the extent that (i) the sum of (A) the 30-day closing price trading average of one Share of common stock of the Issuer ("Share") and (B) the Aggregate Cash Distributions is equal to or greater than $19.12 on any day following the expiration of the post-offering lockup period or (ii) the sum of (X) the value of all consideration that is distributable with respect to one Share in connection with a Corporate Event and (Y) the Aggregate Cash Distributions is equal to or greater than $20.86 as of the effective date of such Corporate Event.